Chemist

Regis Expands Facilities to Support Rising Demand for U.S.-Based Custom API Pharmaceutical Development and Manufacturing

Retrieved on: 
Wednesday, February 17, 2021
Research, Infectious diseases, Clinical trials, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Articles, Natural sciences, Chemistry, Clinical data management, Clinical research, Pharmaceutical industry, Quality, Validation, Validity, Process chemistry, Chemist, API

It increases capabilities across Regis custom pharmaceutical service offerings, including analytical development, process chemistry, solid state chemistry , validation, stability studies, and commercialization.

Key Points: 
  • It increases capabilities across Regis custom pharmaceutical service offerings, including analytical development, process chemistry, solid state chemistry , validation, stability studies, and commercialization.
  • View the full release here: https://www.businesswire.com/news/home/20210217005052/en/
    Siead Zegar, Director of Process Chemistry at Regis Technologies, in the companys 9,000-square-foot expansion of its custom API development laboratories in Morton Grove, IL.
  • (Photo: Business Wire)
    Regis specializes in serving the API development and manufacturing needs of mid-sized and emerging pharmaceutical and biotechnology companies.
  • We offer a full range of services to support the development of our clients' lead molecules from preclinical and clinical API through commercialization, including process research and development, solid state chemistry, analytical development, stability services, GMP API manufacturing, and micronization.

New York University Professor of Chemistry Dr. Kent Kirshenbaum Named Chief Scientific Officer at Maxwell Biosciences

Retrieved on: 
Tuesday, February 16, 2021
Health, Infectious diseases, Other Science, General Health, Research, Science, Pharmaceutical, Chemist

Dr. Kirshenbaum assumes the leadership position at Maxwell while retaining his faculty position at NYU.

Key Points: 
  • Dr. Kirshenbaum assumes the leadership position at Maxwell while retaining his faculty position at NYU.
  • Maxwell Biosciences has also entered into a license with New York University to license patents developed as a result of Dr. Kirshenbaums breakthrough discoveries in new therapeutic technologies.
  • Dr. Kirshenbaum is the co-founder of New York Universitys Biomedical Chemistry Institute and has trained a large number of scientists at the interface of chemistry and the life sciences.
  • in Chemistry from Reed College, a Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco and was an N.I.H.

Snapdragon Chemistry Receives $1.5m DARPA Grant to Develop Continuous Technology for US-based Manufacturing

Retrieved on: 
Tuesday, February 9, 2021
Articles, DARPA, Qualcomm Snapdragon, Science and technology, Chemist, Fine chemical, Chemical engineering, Chemical industry, Academic disciplines

Snapdragon is using the grant money to develop its highly automated continuous manufacturing platform to convert chemicals into valuable starting materials for pharmaceutical manufacturing.

Key Points: 
  • Snapdragon is using the grant money to develop its highly automated continuous manufacturing platform to convert chemicals into valuable starting materials for pharmaceutical manufacturing.
  • "We are thrilled to be selected by DARPA to further our development efforts," said Matthew Bio, President, and CEO of Snapdragon Chemistry.
  • The technology platforms developed in-house by Snapdragon and enhanced by the DARPA grant will help usher in a new era of chemistry and pharmaceutical production.
  • Snapdragon Chemistry is a chemical technology firm providing contract development services for pharmaceutical and fine chemical manufacturing.

P2 Science Appoints Dr. Theodore Anastasiou as Vice President R&D

Retrieved on: 
Friday, January 8, 2021
Physical sciences, Paul Anastas, Articles, Anastas, Firmenich, Green chemistry, P2, Chemist, Yale University

WOODBRIDGE, Conn., Jan. 8, 2021 /PRNewswire-PRWeb/ -- P2 Science Inc ., a green chemistry company, announced that Dr. Theodore Anastasiou has joined the senior management ranks of the company to lead all technical and research & development activities.

Key Points: 
  • WOODBRIDGE, Conn., Jan. 8, 2021 /PRNewswire-PRWeb/ -- P2 Science Inc ., a green chemistry company, announced that Dr. Theodore Anastasiou has joined the senior management ranks of the company to lead all technical and research & development activities.
  • He comes to P2 after leading North American homecare technical development and innovation at Firmenich.
  • "We are extremely pleased to be able to bring into P2, someone of Ted's incredible technical caliber," said P2 CEO, Neil Burns.
  • P2 Science is a green chemistry company, co-founded by Professor Paul Anastas, head of the Yale Center for Green Chemistry and Green Engineering.

GC3 Applauds Enactment of Sustainable Chemistry R&D Act

Retrieved on: 
Monday, January 4, 2021
Articles, Physical sciences, Chemist, Sustainability, Green chemistry

WASHINGTON, Jan. 4, 2021 /PRNewswire/ --The Green Chemistry & Commerce Council (GC3) applauds the passage of the Sustainable Chemistry Research & Development Act.

Key Points: 
  • WASHINGTON, Jan. 4, 2021 /PRNewswire/ --The Green Chemistry & Commerce Council (GC3) applauds the passage of the Sustainable Chemistry Research & Development Act.
  • Sustainable chemistry is the scientific discipline that allows innovators to redesign products and manufacturing processes starting at the molecular level, so they have better health, environmental and energy use profiles.
  • The Sustainable Chemistry R&D Act helps coordinate efforts across all federal agencies to accelerate US innovation in this emerging area of market growth.
  • - Gregg Renfrew, Founder and CEO, Beautycounter
    "BASF proudly supports the Sustainable Chemistry Research and Development Act.

Chemical Activity Barometer Climbs In December

Retrieved on: 
Tuesday, December 29, 2020
Applied sciences, Indicator, Chemistry, Chemical industry, Chemist, Pigment, Measuring instrument, Thermodynamic activity, Branches of science, Science

WASHINGTON, Dec. 29, 2020 /PRNewswire/ -- The Chemical Activity Barometer (CAB) , a leading economic indicator created by the American Chemistry Council (ACC), rose 1.1% in December on a three-month moving average (3MMA) basis, unchanged from November and October.

Key Points: 
  • WASHINGTON, Dec. 29, 2020 /PRNewswire/ -- The Chemical Activity Barometer (CAB) , a leading economic indicator created by the American Chemistry Council (ACC), rose 1.1% in December on a three-month moving average (3MMA) basis, unchanged from November and October.
  • Despite strength in housing activity, trends in construction-related resins, pigments and related performance chemistry were mixed.
  • The CAB is a leading economic indicator derived from a composite index of chemical industry activity.
  • Due to its early position in the supply chain, chemical industry activity has been found to consistently lead the U.S. economy's business cycle, and the barometer can be used to determine turning points and likely trends in the broader economy.

Chemical Industry Outlook: Recovery From The COVID-19 Global Recession

Retrieved on: 
Wednesday, December 9, 2020
Chemist, Chemical industry

With the recovery that began in Q3 firmly in place and improvement in many key chemistry-consuming industries, the outlook is positive.

Key Points: 
  • With the recovery that began in Q3 firmly in place and improvement in many key chemistry-consuming industries, the outlook is positive.
  • In March, the U.S. Department of Homeland Security identified the chemical sector and its workers as 'Essential Critical Infrastructure.'
  • Prepared annually by ACC's Economics and Statistics Department, the Year-End 2020 Chemical Industry Situation and Outlook is the association's review of the U.S. and global business of chemistry and the macroeconomy.
  • It offers global and domestic chemical industry data related to production, trade, shipments, capacity utilization, end-use markets, R&D spending, capital spending, employment and wages.

"If You Don't Shoot the Arrow, It Doesn't Hit the Target"--Interview with WPI-MANA Researcher

Retrieved on: 
Tuesday, November 24, 2020
Articles, Physical sciences, Matter, Phases of matter, In science, Science and technology in the Netherlands, Spintronics, Superconductivity, Solid, Physics, Chemistry, Chemist

The group is also developing cables incorporating new superconducting materials.

Key Points: 
  • The group is also developing cables incorporating new superconducting materials.
  • So the team is also developing artificial intelligence for materials search as well as high-pressure technologies.
  • "Superconductivity is of course a physical property, but the reaction between liquid and a solid is soft chemistry.
  • So, by using a combination of physics and soft chemistry, I was able to find this new material.

2020 Market Study on Metal Surface Treatment Chemical Suppliers - Leadership Quadrant and Strategic Positioning - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 5, 2020
Chemicals, Plastics, Manufacturing, Steel, Biomaterials, Titanium, Chemist, Science, Articles

The "Leadership Quadrant and Strategic Positioning of Metal Surface Treatment Chemical Suppliers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Leadership Quadrant and Strategic Positioning of Metal Surface Treatment Chemical Suppliers" report has been added to ResearchAndMarkets.com's offering.
  • Major players in metal surface treatment chemical market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives.
  • The analyst, a leading global management consulting and market research firm, has analyzed the global metal surface treatment chemical suppliers and has come up with a comprehensive research report, "Leadership Quadrant and Strategic Positioning of Metal Surface Treatment Chemical Suppliers".
  • Using its proprietary research methodology, the analyst has developed a comparative analysis tool, the 'Leadership Quadrant,' which identifies leaders, contenders, visionaries, and specialists in the metal surface treatment chemical market and rates each metal surface treatment chemical producer.

Circle Pharma Appoints James Aggen, PhD as Its Vice President, Medicinal Chemistry

Retrieved on: 
Monday, October 26, 2020
Research, Venture capital, Genetics, Professional services, Biotechnology, Health, Pharmaceutical, Science, Oncology, Cheminformatics, Medicinal chemistry, Chemist

James Aggen, PhD has joined Circle Pharma as its Vice President of Medicinal Chemistry and will lead Circles chemistry team in its discovery and development of macrocycle therapeutics against intractable cancer targets.

Key Points: 
  • James Aggen, PhD has joined Circle Pharma as its Vice President of Medicinal Chemistry and will lead Circles chemistry team in its discovery and development of macrocycle therapeutics against intractable cancer targets.
  • Dr. Aggen has over 20 years of experience in medicinal chemistry.
  • He most recently served as the Senior Director of Medicinal Chemistry at Revolution Medicines and earlier in his career held positions at Oligiasis, Achaogen, Chemocentryx, Gilead Sciences and Theravance.
  • In addition, Jim held the role of Associate Professor of Medicinal and Natural Products Chemistry at Northeastern University.